We are proud to announce that our CEO, Gevorg Tamamyan, has been selected as the recipient of the SLACOM 2026 Award for Global Oncology Leadership by the Latin American and Caribbean Society of Medical Oncology.
This prestigious international recognition highlights Dr. Tamamyan’s outstanding leadership in pediatric oncology, his global contributions to cancer research and care, and his continued efforts to strengthen international collaboration through the Global Cancer Movement.
The award ceremony will take place during the SLACOM Reunion-ASCO 2026 in Chicago, alongside the ASCO Annual Meeting.
We congratulate our CEO, Gevorg Tamamyan on this remarkable international achievement and are proud to see his dedication and impact recognized on the global stage.
About IMMONC
Immune Oncology Research Institute (IMMONC) is dedicated to advancing research aimed at preventing, treating, and ultimately curing cancer while making these innovations accessible to those who need them. If you're interested in joining our team, please feel free to contact us at [email protected] or at +374-41 310-048